To print this article, all you need is to be registered or login on Mondaq.com.
Although Department of Justice ( DOJ ) recoveries
under the False Claims Act ( FCA ) reached historic lows
in fiscal year 2020, President Biden s administration is poised
to usher in a return to aggressive FCA enforcement. Under President
Obama, DOJ s FCA recoveries hit all-time peaks, totaling over
$5 billion in 2012, $6.1 billion in 2014, and $4.9 billion in 2016.
From there, they trended consistently downward throughout the Trump
Administration, averaging under $3 billion annually. Given the
Biden Administration s focus on tackling the COVID-19 pandemic
and stimulating the economy, we anticipate that DOJ s scrutiny
of alleged fraud in government programs will be as probing as
FDA Inspections: Are Changes On The Horizon?
By Kalah Auchincloss, SVP & deputy general counsel, Greenleaf Health, Inc.
Almost exactly one year ago, in March 2020, the U.S. FDA announced that it was suspending all foreign and domestic inspections except those it deemed “mission critical.”[1] This unusual move was a response to the then-emerging COVID-19 pandemic an attempt to reduce transmission of the virus and protect both FDA personnel and industry employees.
Even as it suspended inspections, the agency assured the public that it had “full confidence in the safety and quality of the products we all use every day and that the FDA will continue to leverage all available authorities to continue to ensure the integrity of the products we regulate.”[2] A year into the pandemic, the FDA is still conducting only limited inspections in the U.S. and evidence has emerged of a significant inspection backlog that could compromise the safety and quality of the U.S. drug supply.
Share this article
Share this article
WASHINGTON, April 5, 2021 /PRNewswire/ In an issue jam-packed with intriguing interviews, smart advice and eye-opening reports, cover star Michael Douglas delivers on all three. The Golden Globe, Emmy and Oscar Award-winning actor and producer discusses life lessons about his career, family, fatherhood, and his focus on future work, with no plans to retire anytime soon.
This month s issue also offers all-new conversations with Jackson Browne and Sharon Stone, plus a particularly timely health report to help all Americans over 50 recover from the physical and mental effects of a year living with a pandemic. You ll also find a wide range of smart money information, clever meal prep ideas, what s next up on TV and in the movies, and much more.
A year after passage of Cares Act, watchdogs struggle to oversee trillions in coronavirus spending Updated: 1 hour ago
Print article When the $2.1 trillion Cares Act was enacted just over a year ago, Democrats in Congress, mistrustful of the Trump administration’s ethical track record, made robust policing a top priority for the gusher of new spending. The law, intended to stem the economic pain caused by the coronavirus pandemic, created new oversight bodies and directed more than $270 million to new and existing watchdogs. A House subcommittee with the power to issue subpoenas quickly got to work with queries to private corporations and government agencies.
Watchdogs struggle to oversee trillions in coronavirus spending washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.